Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 200-709-7 | CAS number: 69-53-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: oral
Administrative data
- Endpoint:
- sub-chronic toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other: Equivalent or similar to OECD Guideline 408 (Repeated Dose 90-Day Oral Toxicity in Rodents), with deviations (no data on haematology, clinical biochemistry and organ weight measurements)
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 980
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 408 (Repeated Dose 90-Day Oral Toxicity Study in Rodents)
- Deviations:
- yes
- Remarks:
- (No data on haematology, clinical biochemistry and organ weight measurements)
- GLP compliance:
- no
- Limit test:
- no
Test material
- Reference substance name:
- (2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid trihydrate
- Cas Number:
- 7177-48-2
- Molecular formula:
- C16H25N3O7S
- IUPAC Name:
- (2S,5R,6R)-6-{[(2R)-2-amino-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid trihydrate
- Details on test material:
- - Name of test material (as cited in study report): Ampicillin trihydrate
- Lot/batch No.: 61849K
- Other:
Supplier: E.R. Squibb & Sons, Inc. (Princeton, NJ), manufactured by Ersana, Inc. (Humacao, Puerto Rico)
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Fischer 344
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles Rive:r Breeding Laboratories (Portage, MI)
- Age at study initiation: 7 weeks of age
- Housing: All animals were housed five per cage; Polycarbonate (Lab Products, Int ., Rochelle Park, NJ)
- Diet (e.g. ad libitum): NIH 07 Rat and Mouse Ration (Zeigler Bros , Gardners, PA]; available ad libitum
- Water (e.g. ad libitum): Half deionized/half tap water; automatic watering system (Edstrom Industries, Waterford, VII); available ad libitum.
- Acclimation period: 15 days
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21.44 ± 0.84 ºC
- Humidity (%): 53 ± 7.4%
- Air changes (per hr): 12 room air changes/h
- Photoperiod (hrs dark / hrs light): fluorescent light 12 h/d
IN-LIFE DATES: From 20/12/1979 to 19/3/1980
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- corn oil
- Details on oral exposure:
- - Justification for use and choice of vehicle (if other than water): Ampicillin trihydrate is only slightly soluble in water; therefore, corn oil was selected to improve suspendability in the gavage vehicle.
- Preparation: Weighed ampicillin trihydrate was mixed with corn oil in Waring blender, transferred to volumetric flask and brought to volume with corn oil, mixed in flask, then transferred to a beaker and mixed with a stirring bar and magna-stirrer.
- Amount of vehicle (if gavage): 5 mL/kg bw - Analytical verification of doses or concentrations:
- no
- Duration of treatment / exposure:
- 13 weeks
- Frequency of treatment:
- 5 days/week
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 180, 370, 750, 1500 or 3000 mg/kg ampicillin trihydrate in corn oil by gavage; 3000 mg/kg group given 1500 mg/kg 2 X d at least 5 h apart.
Basis:
actual ingested
- No. of animals per sex per dose:
- 10
- Control animals:
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale:
The highest dose of 3000 mg/kg was selected because no dose-related deaths were seen at 2400 mg/kg in a 14-day study. This dose is the maximum one that was practical to administer to rats (administered as two 1500 mg/kg doses with a dose volume of 5 mL/kg body weight).
Examinations
- Observations and examinations performed and frequency:
- Observation: 2/day
Body weight: 1/week - Sacrifice and pathology:
- Necropsy performed on all animals.
Histologic exams performed on vehicle control and 3000 mg/kg group and on all animals dying during the study.
Tissues examined: regional lymph nodes, skin, mandibular lymph nodes, mammary gland, salivary glands, thigh muscle, sciatic nerve, bone marrow, costo-chondral junction (rib), thymus, larynx, trachea, lungs and bronchi, heart, thyroid gland, parathyroids, esophagus, stomach, duodenum, jejunum, ileum, colon, rectum, mesenteric lymph nodes, liver, pancreas, spleen, kidneys, adrenal glands, urinary bladder, seminal vesicles/prostate/testis or ovaries/uterus, nasal cavity, brain, pituitary gland, eyes, external and middle ear, and spinal cord.
Results and discussion
Results of examinations
- Details on results:
- CLINICAL SIGNS AND MORTALITY
The 12 deaths observed in dosed and vehicle control rats were considered to be due to gavage error.
Male and female rats that received 3000 mg/kg ampicillin trihydrate had diarrhea.
BODY WEIGHT AND WEIGHT GAIN
The final mean body weights of the female rats were not related to the dose levels. The final mean body weight of the males that received 3000 mg/kg was 9% lower than that of the vehicle controls.
GROSS PATHOLOGY
No compound-related gross pathology effects were observed.
HISTOPATHOLOGY
No compound-related histopathologic effects were observed.
No dose-related effects were seen in the 13-week studies at 1500 or 3000 mg/kg.
Effect levels
- Dose descriptor:
- NOEL
- Effect level:
- 3 000 mg/kg bw/day (actual dose received)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- other: see 'Remark'
Target system / organ toxicity
- Critical effects observed:
- not specified
Applicant's summary and conclusion
- Conclusions:
- No dose-related effects were seen in the 13-week study at 1500 or 3000 mg/kg.
- Executive summary:
A thirteen-week study was conducted to evaluate the cumulative toxic effects of repeated administration of ampicillin trihydrate.
Groups of 10 rats of each sex were administered 0,180, 370, 750, 1500, or 3000 mg ampicillin trihydrate/kg in corn oil by gavage, 5 days per week for 13 weeks (dose volume: 5 mL/kg body weight)
Necropsy was performed on all animals. Histologic exams were performed on vehicle control and 3000 mg/kg group and on all animals dying during the study. Tissues examined were: regional lymph nodes, skin, mandibular lymph nodes, mammary gland, salivary glands, thigh muscle, sciatic nerve, bone marrow, costo-chondral junction (rib), thymus, larynx, trachea, lungs and bronchi, heart, thyroid gland, parathyroids, esophagus, stomach, duodenum, jejunum, ileum, colon, rectum, mesenteric lymph nodes, liver, pancreas, spleen, kidneys, adrenal glands, urinary bladder, seminal vesicles/prostate/testis or ovaries/uterus, nasal cavity, brain, pituitary gland, eyes, external and middle ear, and spinal cord.
The final mean body weights of the female rats were not related to the dose levels. The final mean body weight of the males that received 3000 mg/kg was 9% lower than that of the vehicle controls. Male and female rats that received 3000 mg/kg ampicillin trihydrate had diarrhea. No compound-related gross or histopathologic effects were observed.
No dose-related effects were seen in the 13-week study at 1500 or 3000 mg/kg.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.